THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced that its TMINI® Miniature Robotic System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use with the Freedom Total Knee, Freedom Titan Knee, and Freedom Primary PCK Systems from Maxx Orthopedics, Inc. (Norristown, PA) under a Collaboration Agreement between the two companies.
The Freedom Total Knee, Freedom Titan Knee, and Freedom Primary PCK Systems have been added to THINK Surgical’s ID-HUB™, a proprietary data bank of implant modules for use with the open platform version of its TMINI System in the United States.
The Freedom Total Knee and Freedom Titan Knee Systems feature a multi-radius design that accommodates individual patient anatomy, potentially leading to improved alignment and positioning for long-term success. It offers an enhanced range of motion that can achieve flexion up to 155 degrees to help improve functional outcomes for active lifestyles after surgery. Clinically, it has demonstrated strong performance and durability with a 10-year survivorship of 98.3%1.
“Maxx Orthopedics believes in great partnerships and is excited surgeons will have the ability to perform robotic-assisted TKA procedures with our Freedom Total Knee System. Combining our knee solutions with the TMINI System, surgeons can choose from multiple implant options- standard materials to metal sensitivity solutions- and seamlessly perform conventional or robotic-assisted procedures,” said Ashesh Shah, chief executive officer of Maxx Orthopedics.
“THINK Surgical is excited to offer the TMINI System for use with the Freedom Knee System. The open platform version of TMINI is now available with eight different knee designs from eight separate orthopedic companies offering surgeons the choice of single-radius, anatomic (multi-radius), and guided motion knees on a single robotic platform” said Stuart Simpson, president, and chief executive officer of THINK Surgical.
